===
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): AGM/EGM
CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
2024-05-22 / 13:43 CET/CEST
The issuer is solely responsible for the content of this announcement.
CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
. Acts of the governing boards formally approved
. Dividend proposal of EUR 1.00 confirmed
. High approval rates for capital measures
. Focus on data-based solutions and artificial intelligence

Koblenz - The shareholders of CompuGroup Medical SE & Co. KGaA (CGM) approved the dividend proposal of the General
Partner, the Supervisory Board and the Managing Directors at the e-health group's virtual Annual General Meeting (AGM)
on May 22, 2024. As a result, a dividend of EUR 1.00 per share will be paid for the financial year 2023, twice as much
as in the previous year. This corresponds to a payout of around EUR 51.7 million. The shareholders also approved all
proposed capital measures by majorities of more than 90 percent such as the enactment of authorized capital, the
authorization to issue convertible bonds and share options or the authorization to acquire and use treasury shares.
The shareholders approved the annual financial statements of CompuGroup Medical SE & Co. KGaA for 2023 and passed the
remuneration report for 2023. The actions of the General Partner of CompuGroup Medical SE & Co. KGaA and the members of
the Supervisory Board were formally approved.
All other items on the agenda were also approved by the shareholders with a large majority. A total of around 79
percent of the share capital of CompuGroup Medical SE & Co. KGaA was represented at the Annual General Meeting. The
speeches by CEO Michael Rauch and CFO Daniela Hommel, who has been in office since February 1, were published
beforehand online. A video replay of both speeches will be made avaailable subsequently on the company's website.
In his speech, CGM CEO Michael Rauch addressed the 2023 financial year and the future development of the company. He
said: "The medicine of the future will be digital, data-based and interconnected. That is why we are focusing on
data-based solutions, Artificial Intelligence, the analysis of medical data and real-time access. CompuGroup Medical is
well prepared for this future."
CFO Daniela Hommel introduced herself to CGM's shareholders during her first AGM speech. With respect to the
financials, she emphasized that CompuGroup Medical is growing organically at a sustainably high level: "The increase in
revenues and earnings in 2023 contributed to a high free cash flow of EUR 113 million. We have a strong business model.
The results confirm the path that we want to keep pursuing: sustainable profitable growth."
The complete documents relating to the Annual General Meeting can be found on our website: Annual General Meeting -
Investor Relations - Company - cgm.com.
2024-05-22 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      CompuGroup Medical SE & Co. KGaA 

Maria Trost 21
56070 Koblenz
Germany

Phone:        +49 (0)160 3630362 
Fax:          +49 (0)261 8000 3200 
E-mail:       investor@cgm.com 
Internet:     www.cgm.com 
ISIN:         DE000A288904 
WKN:          A28890 
Indices:      SDAX, TecDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 

Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1908843

End of News EQS News Service
===
1908843 2024-05-22 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1908843&application_name=news

END) Dow Jones Newswires

May 22, 2024 07:43 ET (11:43 GMT)